Covid-19 Bending the Curve

McClatchy operates 30 media companies in 14 states, providing each of its communities with strong independent local journalism in the public interest. It publishes iconic brands including the Miami Herald, The Kansas City Star, The Sacramento Bee, The Charlotte Observer, The (Raleigh) News & Observer, and the Fort Worth Star-Telegram.

rsvp

about | speakers | contact

cdubose@mcclatchydc.com

Cynthia DuBose

for speakers

slarrieu@miamiherald.com

silvia larrieu

for sponsors

rsvp

Additional questions: eventinfo@mcclatchy.com

additional SPEAKERS to be announced

Michael Wilner

Innovation & Treatment

A livestreamed three-part series

part 1

Thursday, May 28 12:30 p.m. - 1:30 p.m. EDT

The Path to a Vaccine

part 2

Thursday, June 4 12:30 p.m. - 1:30 p.m. EDT

Impact on Health Care Policy

part 3

Thursday, June 11 12:30 p.m. - 1:30 p.m. EDT

For this series, we are bringing together top-rated medical professionals, industry experts, patient advocates and policymakers to update our audience on the latest advancements to combat the virus. In this first event, our focus will be innovation and treatment; we will explore from three perspectives how our country can accelerate research and innovation toward treatments for patients suffering from COVID-19. The following installments will focus on the path to a vaccine and the long-term impact of this crisis on health care policy. McClatchy’s “COVID-19: Bending the Curve” series is designed to be a true exchange of ideas, in a civil forum focused on solutions. With more than 15,000 stories on the COVID-19 crisis to date, McClatchy’s newsrooms have been delivering comprehensive coverage of this pandemic, reaching over 60 million readers and viewers who look to us for essential journalism. These events will provide a unique opportunity to reach those state and local audiences across the country, as it will be livestreamed simultaneously to all of McClatchy’s 30 news sites. The event series is being underwritten by PhRMA.

presented by

COVID-19 Bending the Curve

rsvp

Speakers

White House Correspondent, McClatchy

Innovation & Treatment

The Path to a Vaccine

Impact on Health Care Policy

Steve Stites, MD

Exec. VP of Clin. Affairs & CMO, The University of Kansas Health System

Ray Deshaies, Ph.D.

Sr. VP of Global Research, Amgen

The Beaufort Gazette Belleville News-Democrat The Bellingham Herald (Biloxi) Sun Herald (Boise) Idaho Statesman Bradenton Herald The Charlotte Observer The (Columbia) State (Columbus) Ledger-Enquirer The (Durham) Herald-Sun Fort Worth Star-Telegram The Fresno Bee The (Hilton Head) Island Packet The Kansas City Star Lexington Herald-Leader The (Macon) Telegraph Merced Sun-Star Miami Herald (Miami) El Nuevo Herald The Modesto Bee The (Myrtle Beach) Sun News The Olympian The (Raleigh) News & Observer The (Rock Hill) Herald The Sacramento Bee The (San Luis Obispo) Tribune (State College) Centre Daily Times The (Tacoma) News Tribune Tri-City Herald The Wichita Eagle

Contact

Additional questions: eventinfo@mcclatchy.com

cdubose@mcclatchydc.com

Cynthia DuBose

for speakers

slarrieu@miamiherald.com

silvia larrieu

for sponsors

Contact

Impact to Health Care Policy

The Path to a Vaccine

Innovation & Treatment

additional SPEAKERS to be announced

Speakers

For this series, we are bringing together top-rated medical professionals, industry experts, patient advocates and policymakers to educate our audience on the latest advancements to combat the virus. In this first event, our focus will be innovation and treatment; we will explore from three perspectives how our country can accelerate research and innovation toward treatments for patients suffering from COVID-19. The following installments will focus on the path to a vaccine and the long-term impact of this crisis on health care policy. McClatchy’s “COVID-19: Bending the Curve” series is designed to be a true exchange of ideas, in a civil forum focused on solutions. With more than 15,000 stories on the COVID-19 crisis to date, McClatchy’s newsrooms have been delivering comprehensive coverage of this pandemic, reaching over 60 million readers and viewers who look to us for essential journalism. These events will provide a unique opportunity to reach those state and local audiences across the country, as it will be live-streamed simultaneously to all of McClatchy’s 30 news sites. The event series is being underwritten by PhRMA.

COVID-19 Bending the Curve

presented by

Thursday, June 11 12:30 p.m. - 1:30 p.m. EDT

Impact to Health Care Policy

part 3

Thursday, June 4 12:30 p.m. - 1:30 p.m. EDT

The Path to a Vaccine

part 2

Thursday, May 28 12:30 p.m. - 1:30 p.m. EDT

Innovation & Treatment

part 1

Live-streamed 3-part event series

From the 30 local newsrooms that together make McClatchy

McClatchy Virtual Event Series

presented by

moderator

Michael Wilner

moderator

White House Correspondent, McClatchy

Michael Wilner, a White House correspondent for McClatchy, has led coverage of the Trump administration’s response to the coronavirus. Wilner’s out front coverage of the unfolding pandemic has included deep dives on the nation’s initial shortages of tests, ventilators and masks, pressures facing the FDA, and the push for a vaccine. Wilner holds degrees from Claremont McKenna College and Columbia University and is a native of New York City.

Bio

Steve Stites, MD serves a dual role as vice chancellor for clinical affairs and senior vice president for clinical affairs for The University of Kansas Hospital Authority. He served as chair of the University of Kansas Medical Center Department of Internal Medicine from 2007-2014 and was the interim executive vice chancellor for 10 months; from 2000-2008 he was the residency program director in internal medicine. Dr. Stites received his medical degree from the University of Missouri-Columbia. He completed his residency and chief residency in internal medicine at the University of Rochester and fellowship at the University of Kansas Medical Center.

Steve Stites, MD

Exec. VP of Clin. Affairs & CMO, The University of Kansas Health System

Raymond Deshaies, Ph.D., is senior vice president, Global Research at Amgen. Prior to joining Amgen, Deshaies served as a professor at the California Institute of Technology and an executive officer in Caltech’s Division of Biology and Biological Engineering. He was also an investigator at the Howard Hughes Medical Institute. Deshaies co-founded Proteolix in 2003. In 2011, he co-founded Cleave Biosciences. Deshaies holds a bachelor's degree in biochemistry from Cornell University and a Ph.D. in biochemistry from the University of California, Berkeley. He is a member of the National Academy of Sciences, and American Academy of Arts and Sciences.

Ray Deshaies, Ph.D.

Sr. VP of Global Research, Amgen

Bio

A message from the sponsor

Bio

Assistant Professor, University of Kentucky

Zach Porterfield, MD

Dr. Zach Porterfield is a physician scientist with specialization in infectious disease, virology, and global health. He is an Assistant Professor at the University of Kentucky where he sees patients and directs research focused on the immune response to viral infections with a special focus on HIV. He splits his time between Lexington, Kentucky and South Africa where he works on lab-based and translational research and global health capacity building in collaboration with the Africa Health Research Institute and the University of KwaZulu-Natal. He directs global health research projects in multiple sites in Africa and the United States and is invested in developing treatments that can reach a global community. He is co-principle investigator of the drug trail for COVID-19 treatment at the University of Kentucky and co-investigator on a second clinical trial studying the use of iodine nasal spray to protect our most vulnerable healthcare workers and patients from COVID-19 infection.

Assistant Professor, University of Kentucky

Zach Porterfield, MD

Bio

White House Correspondent, McClatchy

Michael Wilner

Senior Vice President, Global Research, Amgen

Ray Deshaies, Ph.D.

Senior Vice President, Global Research, Amgen

Bio

Senior Vice President, Global Research, Amgen

Ray Deshaies, Ph.D.

Natalie Dean, Ph.D.

Assistant Professor of the Department of Biostatistics, University of Florida

Bio

Audrey Dutton

Investigative Reporter, Idaho Statesman

Bio

Dr. Natalie Dean is an Assistant Professor in the Department of Biostatistics at the University of Florida specializing in infectious disease epidemiology and study design. Her research is on innovative strategies to evaluate the efficacy of vaccines targeting emerging pathogens. She previously worked on the design and analysis of a Phase 3 Ebola vaccine trial in Guinea that used a novel ring vaccination approach. Dr. Dean received her PhD in Biostatistics from Harvard University in 2014. She has also worked as a statistical consultant for the World Health Organization’s HIV Department.

Assistant Professor of the Department of Biostatistics, University of Florida

Natalie Dean, Ph.D.

Audrey Dutton is an investigative reporter for the Idaho Statesman. She has covered health care in Idaho since 2011, reporting mainly on the business of health care and on Idaho's mental health system. Before COVID-19 became her primary beat, she wrote occasionally about outbreaks and vaccines, including a story in February about self-described "vaccine refugees" moving from California to Idaho, where immunization rules are lax. Twitter: @audreydutton

Investigative Reporter, Idaho Statesman

Audrey Dutton

moderator

Assistant Professor, University of Kentucky

Zach Porterfield, MD

Investigative Reporter, Idaho Statesman

Audrey Dutton

Assistant Professor, University of Kentucky

Zach Porterfield, MD

Investigative Reporter, Idaho Statesman

Audrey Dutton

moderator

Bio

President & CEO, PhRMA

Stephen J. Ubl

sponsor remarks

Stephen J. Ubl is president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents America's leading biopharmaceutical research companies. Mr. Ubl leads PhRMA's work preserving and strengthening a health care and economic environment that encourages medical innovation, new drug discovery, and access to life-saving medicines. “If anyone can find areas of agreement with the critics, or at least work productively with them, it may be Mr. Ubl," the New York Times wrote in February 2016. "He is more conversant with the intricacies of health policy, and more adept at the politics." He is routinely recognized as one of Washington’s most effective advocates, and, in 2019, was named one of Business Insider’s “DC Healthcare Power Players.”

President & CEO, PhRMA

Stephen J. Ubl

sponsor remarks

Bio

VP of News, McClatchy

Kristin Roberts

welcome remarks

Kristin Roberts is McClatchy’s vice president of News and the first woman to hold that position in the company’s 160+ year history. She leads 30 newsrooms focused on delivering local news and information that is essential to the lives of readers and viewers in communities across the US.

VP of News, McClatchy

Kristin Roberts

welcome remarks

Michael Wilner joined McClatchy as its White House correspondent in 2019. He previously served as Washington bureau chief for The Jerusalem Post, where he led coverage of the Iran nuclear talks, the Syrian refugee crisis and the 2016 US presidential campaign. Wilner holds degrees from Claremont McKenna College and Columbia University and is a native of New York City.

White House Correspondent, McClatchy

Michael Wilner

moderator

VP of News, McClatchy

Kristin Roberts

sponsor remarks

Sr. VP of Global Research, Amgen

Ray Deshaies, Ph.D.

Join the live event

Jonathan D. Quick, MD, MPH

Managing Director, Response, Preparedness and Prevention, The Rockefeller Foundation

Bio

Dr. Jonathan “Jono” Quick is the Managing Director for Response, Preparedness and Prevention at The Rockefeller Foundation. He has extensive experience in international public health including with the World Health Organization, Management Sciences for Health and the Duke Global Health Institute. He is the author of The End of Epidemics: The Looming Threat to Humanity and How to Stop It. https://www.endofepidemics.com/

Managing Director, Response, Preparedness and Prevention, The Rockefeller Foundation

Jonathan D. Quick, MD, MPH

Assistant Professor of the Department of Biostatistics, University of Florida

Natalie Dean, Ph.D.

Assistant Professor of the Department of Biostatistics, University of Florida

Natalie Dean, Ph.D.

Leonard Friedland, MD

VP, Director of Scientific Affairs and Public Health, Vaccines, North America at GlaxoSmithKline (GSK)

Bio

Dr. Leonard Friedland is a licensed pediatrician in the state of Pennsylvania. He has held many positions in clinical research and development with GSK since 2003, specializing in infectious disease vaccination. Prior to his work at GSK, Dr. Friedland was Division Chief, Pediatric Emergency Medicine, at Temple University School of Medicine. Dr. Friedland is currently a fellow and active member of the American Academy of Pediatrics. He has published over 39 peer-reviewed articles during his career. Dr. Friedland studied medicine at Mount Sinai School of Medicine in New York and conducted his residency in pediatrics at the Children’s Hospital of Philadelphia and his fellowship in pediatric emergency medicine at St. Christopher’s Hospital for Children, also in Philadelphia.

VP, Director of Scientific Affairs and Public Health, Vaccines, North America at GlaxoSmithKline (GSK)

Leonard Friedland, MD

Did you miss Bending the Curve, Innovation & Treatment? Watch a recording of the event.

SPONSOR REMARKS ON BEHALF OF PhRMA

Investigative Reporter, Idaho Statesman

Audrey Dutton

SPONSOR REMARKS ON BEHALF OF PhRMA

Bill Gruber, MD

Sr. VP of Vaccine Clinical Research and Development, WRDM, Pfizer Inc.

Bio

Bill is Senior Vice President of Pfizer Vaccine Clinical Research and Development, and responsible for global clinical research and development of vaccines to meet licensure and post licensure requirements. He has over 35 years of experience in vaccine development. Bill joined in 1999 as Vice President of Clinical Vaccine Research and Development for Wyeth, now a wholly owned subsidiary of Pfizer Inc. Other prior experience includes: Associate Professor of Pediatrics in the Division of Pediatric Infectious Diseases, Vanderbilt University School of Medicine, Director of the Diagnostic Virology Laboratory at Vanderbilt University Hospital.

Sr. VP of Vaccine Clinical Research and Development, WRDM, Pfizer Inc.

Bill Gruber, MD

Investigative Reporter, Idaho Statesman

Audrey Dutton

Amy Driscoll

Editor Health Policy and Politics, Miami Herald

Bio

moderator

Donna Shalala

Congresswoman, Florida's 27th District

Bio

Amy Driscoll is the editor for health policy and politics at the Miami Herald, where she has worked as an award-winning reporter, editor and podcaster. She's a former Nieman Fellow and co-creator of the photo archive site, Flashback Miami. Most recently, she co-hosted and reported the Miami Herald's six-part narrative podcast, Smoked, that traces the life of a 1980s pot smuggling kingpin who emerged from prison into a world where marijuana is increasingly legal. She's a second-generation journalist.

Editor Health Policy and Politics, Miami Herald

Amy Driscoll

Congresswoman Donna Shalala represents Florida’s 27th District, which includes the City of Miami and surrounding municipalities. She has dedicated her life to public service and is the longest-serving Secretary of Health and Human Services in U.S. history. In 2008, she was awarded the Presidential Medal of Freedom, the nation’s highest civilian award. She has been inducted to the National Women’s Hall of Fame and she has more than five dozen honorary degrees. A distinguished scholar and academic administrator, she served as President of Hunter College, Chancellor of the University of Wisconsin—Madison, and President of the University of Miami.

Congresswoman, Florida's 27th District

Donna Shalala

Bio

Chief Operating Officer, PhRMA

Lori M. Reilly, Esq.

sponsor remarks

Lori M. Reilly is chief operating officer at the Pharmaceutical Research and Manufacturers of America (PhRMA), providing executive level management, leadership and strategic direction for the organization. In this role, Ms. Reilly oversees PhRMA’s advocacy activities, including its federal, state and international government affairs and alliance development work. Ms. Reilly works across PhRMA to develop and advocate for practical policy solutions that will lower costs for patients. Ms. Reilly, named by The Hill as a top lobbyist in 2018, has a long record of working with members of Congress on a bipartisan basis and collaborating with stakeholders across the health care industry. Ms. Reilly received a B.A. in political science from the University of Nebraska-Lincoln where she graduated with honors, and a J.D. from the University of Nebraska College of Law.

Chief Operating Officer, PhRMA

Lori M. Reilly, Esq.

sponsor remarks

Ana Viamonte Ros, MD, MPH

Medical Director, Bioethics and Palliative Care, Baptist Health South Florida Florida Surgeon General and Secretary of the Department of Health (2007-2011)

Bio

Dr. Ana Viamonte Ros currently serves as Medical Director of Palliative Care and Bioethics Services at Baptist Health South Florida. She is also Associate Professor at the Herbert Wertheim College of Medicine at Florida International University. Previously, Dr. Viamonte Ros served as Florida's first State Surgeon General and first woman and Cuban American to head the Florida Department of Health from 2007-11. Through her professional and community volunteer activities, she is committed to advancing the opportunities for equitable and accessible health care to all.

Medical Director, Bioethics and Palliative Care, Baptist Health South Florida Florida Surgeon General and Secretary of the Department of Health (2007-2011)

Ana Viamonte Ros, MD, MPH

Beth McGraw, PhD

Director, Center for Infectious Disease Dynamics Professor and Huck Scholar in Entomology, Penn State

Bio

Elizabeth McGraw is a professor and Huck Scholar in entomology and the director of the Center for Infectious Disease Dynamics. McGraw’s research investigates how genetic diversity and coevolutionary forces of vector, pathogen, and symbiont interactions affect the transmission of arboviruses. She recently wrote about super spreaders in light of the coronavirus outbreak for The Conversation and was featured in timely news articles from top-tier news outlets such as the BBC, TIME, NPR, and NBC News.

Director, Center for Infectious Disease Dynamics Professor and Huck Scholar in Entomology, Penn State

Beth McGraw, PhD

Anand Parekh, MD, MPH

Chief Medical Advisor, Bipartisan Policy Center

Bio

Anand Parekh is the Bipartisan Policy Center’s chief medical advisor providing clinical and public health expertise across the organization. Prior to joining BPC, he completed a decade of service at the U.S. Department of Health and Human Services. Parekh is a board-certified internal medicine physician, a fellow of the American College of Physicians, an adjunct professor of health management and policy at the University of Michigan School of Public Health, and an adjunct assistant professor of medicine at Johns Hopkins University. His book Prevention First: Policymaking for a Healthier America argues that prevention must be our nation’s top health policy priority.

Chief Medical Advisor, Bipartisan Policy Center

Anand Parekh, MD, MPH

Sr. VP of Vaccine Clinical Research and Development, WRDM, Pfizer Inc.

Bill Gruber, MD

sponsor remarks

Investigative Reporter, Idaho Statesman

Audrey Dutton

Congresswoman, Florida's 27th District

Donna Shalala

Medical Director, Bioethics and Palliative Care, Baptist Health South Florida Florida Surgeon General and Secretary of the Department of Health (2007-2011)

Ana Viamonte Ros, MD, MPH

Investigative Reporter, Idaho Statesman

Audrey Dutton

moderator

President & CEO, PhRMA

Stephen J. Ubl

sponsor remarks

moderator

Managing Director, Response, Preparedness and Prevention, The Rockefeller Foundation

Jonathan D. Quick, MD, MPH

sponsor remarks

President & CEO

Stephen J. Ubl

sponsor remarks

White House Correspondent, McClatchy

Michael Wilner

moderator

Editor Health Policy and Politics, Miami Herald

Amy Driscoll

Chief Medical Advisor, Bipartisan Policy Center

Anand Parekh, MD

Chief Medical Advisor, Bipartisan Policy Center

Anand Parekh, MD

Linda Goler Blount, MPH

President and CEO, Black Women's Health Imperative

Bio

Linda Goler Blount joined the Black Women’s Health Imperative in 2014. As president and CEO of the only national organization focused on Black women’s emotional, physical and financial health, Linda has overseen more than $20 million invested in Black women and research to prevent chronic disease and HIV, ensure reproductive justice and healthy maternal outcomes and advocate for health promoting policies. Linda, an epidemiologist, edited IndexUS, the first research on Black women’s health based on healthy Black women. Her career includes successful tenures at CDC, the Coca-Cola Company and consulting with health ministries in countries in Europe, Africa and the Caribbean.

President and CEO, Black Women's Health Imperative

Linda Goler Blount, MPH

Chief Medical Advisor, Bipartisan Policy Center

Anand Parekh, MD

Congresswoman, Florida's 27th District

Donna Shalala

Did you miss Bending the Curve, The Path to a Vaccine? Watch a recording of the event.

Did you miss Bending the Curve, Innovation & Treatment? Watch a recording of the event.

Peter Pitts

President, Center for Medicine in the Public Interest Visiting Professor at Université de Paris Descartes Medical School

Bio

Peter Pitts is a Visiting Professor at Université de Paris Descartes Medical School and President of the Center for Medicine in the Public Interest. He is a former member of the United States Senior Executive Service and Associate Commissioner of the Food & Drug Administration. Pitts is a member of the Council for International Organizations of Medical Sciences (CIOMS) Expert Working Group to help advance patient involvement in the development and safe use of medicines. He is the lead author of many professional peer reviewed publications including the Lancet, Therapeutic Innovation and Regulatory Science, and Nature Biotechnology. His new book is “Common Sense Healthcare for Common Sense Americans – and Presidential Candidates.”

President, Center for Medicine in the Public Interest Visiting Professor at Université de Paris Descartes Medical School

Peter Pitts

Editor Health Policy and Politics, Miami Herald

Amy Driscoll

Editor Health Policy and Politics, Miami Herald

Amy Driscoll

We are excited to partner with McClatchy on the “Bending the Curve” series to highlight the work that is being done to put an end to the coronavirus pandemic and to prepare for the future. It is an important conversation and one that will showcase the expertise of people across the globe who are working tirelessly to beat COVID-19. America's biopharmaceutical companies are doing our part to fight coronavirus. We are working around the clock in conjunction with other life science companies to develop new diagnostics to test for the virus and our companies are rapidly screening their vast global libraries of medicines to identify potential treatments and outlining processes to make those medicines available to patients. Our companies are also on the frontlines tackling COVID-19 by developing new therapies and treatments for those infected with the virus, as well as working to develop a vaccine to prevent future infections. The decades-long investments of biopharmaceutical companies, and learnings from past epidemics such as SARS, MERS and Ebola, have prepared us to act swiftly to respond to this public health crisis. The biopharmaceutical industry will continue to work with health care partners, public health officials and policymakers to do everything we can to beat this virus as quickly as possible. And when we succeed, we will use this experience to prepare for the future, ensuring we continue to support patients and communities across the United States and the world. This vision and the selflessness of people around the globe who are working to end this pandemic, inspires us to keep fighting. To stay informed on the latest updates from the industry, visit phrma.org/coronavirus. Please stay safe and healthy. Pharmaceutical Research and Manufacturers of America

A message from the sponsor

McClatchy Virtual Event Series

covid-19: bending the curve

McClatchy Virtual Event Series

Back